D. Boral Capital Begins Coverage on QT Imaging (NASDAQ:QTI)

Stock analysts at D. Boral Capital started coverage on shares of QT Imaging (NASDAQ:QTI) in a note issued to investors on Friday, Benzinga reports. The brokerage set a “buy” rating and a $9.00 price target on the stock. D. Boral Capital‘s price target would indicate a potential upside of 300.00% from the company’s current price.

A number of other research analysts have also commented on the company. Weiss Ratings restated a “sell (e+)” rating on shares of QT Imaging in a research note on Tuesday, October 6th. Craig Hallum began coverage on shares of QT Imaging in a research note on Monday, October 5th. They set a “buy” rating and a $8.00 price target on the stock. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $8.50.

QT Imaging Stock Performance

QTI traded down $0.11 on Friday, hitting $2.25. 40,627 shares of the stock traded hands, compared to its average volume of 40,864. QT Imaging has a 52 week low of $2.25 and a 52 week high of $8.50. The company has a current ratio of 3.10, a quick ratio of 2.06 and a debt-to-equity ratio of 6.81. The firm has a market capitalization of $30.98 million, a PE ratio of -1.43 and a beta of 0.02. The business has a fifty day moving average price of $2.67 and a two-hundred day moving average price of $3.97.

QT Imaging (NASDAQ:QTI) last announced its quarterly earnings data on Wednesday, August 12th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.53). QT Imaging had a negative return on equity of 1,202.69% and a negative net margin of 77.25%. The firm had revenue of $7.44 million during the quarter, compared to the consensus estimate of $7.60 million. On average, research analysts predict that QT Imaging will post -1.11 EPS for the current fiscal year.

Institutional Investors Weigh In On QT Imaging

Institutional investors and hedge funds have recently made changes to their positions in the company. Stonepine Capital Management LLC bought a new position in QT Imaging during the 2nd quarter valued at about $407,000. Polar Asset Management Partners Inc. acquired a new position in QT Imaging in the second quarter valued at about $210,000. Finally, BlackRock Inc. boosted its position in QT Imaging by 116.5% in the second quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock valued at $250,000 after buying an additional 33,009 shares in the last quarter. Institutional investors and hedge funds own 24.19% of the company’s stock.

About QT Imaging

QT Imaging Holdings, Inc develops medical imaging technology designed to support breast cancer screening and diagnostic procedures. The company’s flagship product, QTscan, is a three-dimensional, transmission-based breast imaging system that uses ultrasound technology to produce images without ionizing radiation, breast compression or injectable contrast agents.

QTscan is intended for use by healthcare providers as an imaging tool for evaluating breast tissue, including in patients with dense breasts.